Evaluation of dolutegravir-and bictegravir-based antiretroviral regimen utilization in patients who cannot take medications by mouth
M LoFaso, O Marchionda, S Bass… - Open Forum …, 2023 - academic.oup.com
A retrospective review of patients unable to take medications by mouth showed short
interruptions of therapy for most patients. In a secondary analysis, our data showed …
interruptions of therapy for most patients. In a secondary analysis, our data showed …
[PDF][PDF] Evaluation of dolutegravir and bictegravir based antiretroviral regimens utilization in patients who cannot take medications by mouth
O Marchionda, S Bass - 2023 - academia.edu
A retrospective review of intensive care patients unable to take antiretrovirals by mouth
showed 56.6% of patients experiencing a transient interruption in therapy. Additionally, our …
showed 56.6% of patients experiencing a transient interruption in therapy. Additionally, our …